Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 12/20 | 0.41 |
| ▸ | HTR6 | P50406 | 1/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3008846 | 0.86 | HTR6 (0.41) | HTR6KCNH2 | |
| Hydrochloric Acid SCHEMBL3016388 | 0.85 | HTR6 (0.41) | HTR6KCNH2 | |
| SCHEMBL3726142 | 0.84 | KDM4C (0.38) | KDM4CKCNH2 | |
| SCHEMBL3016117 | 0.83 | KCNH2 (0.52) | KCNH2 | |
| Hydrochloric Acid SCHEMBL3022236 | 0.82 | KCNH2 (0.51) | KCNH2 | |
| SCHEMBL3725917 | 0.81 | FLT3 (0.35) | KCNH2 | |
| SCHEMBL3029093 | 0.79 | KCNH2 (0.42) | KDM4CKCNH2 | |
| Hydrochloric Acid SCHEMBL3027523 | 0.79 | KCNH2 (0.42) | KDM4CKCNH2 | |
| SCHEMBL3026655 | 0.78 | KCNH2 (0.36) | KCNH2 | |
| SCHEMBL3025294 | 0.78 | KCNH2 (0.46) | KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100197679-A1 | COMPOUNDS | GLAXO GROUP LIMITED | 2010-08-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100197679-A1 | COMPOUNDS | NRDC, MRPL21, NISCH | KDM4C 3322/4885HTR6 3665/4885KCNH2 2445/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.